FI100769B - Menetelmä triglyseridejä sisältävän farmaseuttisen podofyllotoksiiniva lmisteen valmistamiseksi - Google Patents

Menetelmä triglyseridejä sisältävän farmaseuttisen podofyllotoksiiniva lmisteen valmistamiseksi

Info

Publication number
FI100769B
FI100769B FI920428A FI920428A FI100769B FI 100769 B FI100769 B FI 100769B FI 920428 A FI920428 A FI 920428A FI 920428 A FI920428 A FI 920428A FI 100769 B FI100769 B FI 100769B
Authority
FI
Finland
Prior art keywords
podophyllotoxin
preparing
pharmaceutical preparation
containing triglycerides
triglycerides
Prior art date
Application number
FI920428A
Other languages
English (en)
Swedish (sv)
Other versions
FI920428A0 (fi
Inventor
Kurt Leander
Jan Gunzinger
Boerje Rosen
Original Assignee
Analytecon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Analytecon Sa filed Critical Analytecon Sa
Publication of FI920428A0 publication Critical patent/FI920428A0/fi
Application granted granted Critical
Publication of FI100769B publication Critical patent/FI100769B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI920428A 1989-07-31 1992-01-30 Menetelmä triglyseridejä sisältävän farmaseuttisen podofyllotoksiiniva lmisteen valmistamiseksi FI100769B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8902624A SE464167B (sv) 1989-07-31 1989-07-31 Topisk farmaceutisk beredning av podophyllotoxin
PCT/SE1990/000492 WO1991001717A1 (en) 1989-07-31 1990-07-17 A podophyllotoxin preparation containing triglycerides

Publications (2)

Publication Number Publication Date
FI920428A0 FI920428A0 (fi) 1992-01-30
FI100769B true FI100769B (fi) 1998-02-27

Family

ID=20376598

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920428A FI100769B (fi) 1989-07-31 1992-01-30 Menetelmä triglyseridejä sisältävän farmaseuttisen podofyllotoksiiniva lmisteen valmistamiseksi

Country Status (17)

Country Link
US (1) US6440428B1 (fi)
EP (1) EP0587554B1 (fi)
JP (1) JP3034026B2 (fi)
KR (1) KR0145678B1 (fi)
AT (1) ATE158948T1 (fi)
AU (1) AU633949B2 (fi)
CA (1) CA2064476C (fi)
DE (1) DE69031569T2 (fi)
DK (1) DK0587554T3 (fi)
ES (1) ES2109237T3 (fi)
FI (1) FI100769B (fi)
GB (1) GB2250437B (fi)
HU (1) HU207939B (fi)
NO (1) NO179632C (fi)
RU (1) RU2097032C1 (fi)
SE (1) SE464167B (fi)
WO (1) WO1991001717A1 (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362222B1 (en) 1998-07-17 2002-03-26 Eero Saarela Analgesic use of podophyllotoxin for treating pain conditions in female genital organs

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
DE69705968T2 (de) * 1997-02-14 2002-04-18 De Meeus D'argenteuil, Reginald Zubereitung auf der basis von kokosöl und ihre verwendung
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
EP1729768B1 (en) * 2004-03-15 2018-01-10 Meda AB Immune response modifier formulations and methods
RU2283086C2 (ru) * 2004-07-16 2006-09-10 Пятигорская государственная фармацевтическая академия Способ получения мази на основе липофильной фракции из твердой оболочки кокосового ореха
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826845A (en) * 1969-02-08 1974-07-30 Sankyo Co Ointment base
DE2063896A1 (de) * 1970-12-28 1972-07-20 Dynamit Nobel Ag, 5210 Troisdorf Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung
US4235889A (en) * 1979-04-25 1980-11-25 Pharmazeutische Fabrik Evers & Co. Therapeutic agent for the external treatment of psoriasis, tinea and eczemas
US4341783A (en) * 1980-07-31 1982-07-27 Lemmon Company Topical use of dyphylline and dyphylline containing compositions
IL65588A (en) * 1981-07-10 1985-04-30 Orion Yhtymae Oy Pharmaceutical compositions for the treatment of skin
GB8307614D0 (en) * 1983-03-18 1983-04-27 Pharma Medica As Treatment of genital warts
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
AU585936B2 (en) 1984-12-28 1989-06-29 Conpharm A.B. Pharmaceutically active podophyllotoxins
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4751075A (en) * 1986-01-08 1988-06-14 Redken Laboratories, Inc. Anhydrous cosmetic compositions for thermal skin treatments
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4994496A (en) * 1987-09-09 1991-02-19 Repasky Elizabeth A Use of milk globules as carriers for drugs
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362222B1 (en) 1998-07-17 2002-03-26 Eero Saarela Analgesic use of podophyllotoxin for treating pain conditions in female genital organs

Also Published As

Publication number Publication date
DE69031569D1 (de) 1997-11-13
AU6061690A (en) 1991-03-11
NO179632B (no) 1996-08-12
GB2250437B (en) 1993-05-26
HU9200015D0 (en) 1992-03-30
EP0587554B1 (en) 1997-10-08
CA2064476C (en) 2000-09-12
ES2109237T3 (es) 1998-01-16
WO1991001717A1 (en) 1991-02-21
RU2097032C1 (ru) 1997-11-27
HUT58996A (en) 1992-04-28
EP0587554A1 (en) 1994-03-23
SE464167B (sv) 1991-03-18
JP3034026B2 (ja) 2000-04-17
DE69031569T2 (de) 1998-02-19
KR920703047A (ko) 1992-12-17
ATE158948T1 (de) 1997-10-15
FI920428A0 (fi) 1992-01-30
DK0587554T3 (da) 1997-10-27
US6440428B1 (en) 2002-08-27
JPH05500661A (ja) 1993-02-12
AU633949B2 (en) 1993-02-11
SE8902624D0 (sv) 1989-07-31
CA2064476A1 (en) 1991-02-01
NO920255D0 (no) 1992-01-20
GB2250437A (en) 1992-06-10
HU207939B (en) 1993-07-28
GB9200158D0 (en) 1992-03-11
NO179632C (no) 1996-11-20
KR0145678B1 (ko) 1998-08-17
SE8902624L (sv) 1991-02-01
NO920255L (no) 1992-01-20

Similar Documents

Publication Publication Date Title
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
NO152635C (no) Fremgangsmaate for fremstilling av cyklosporinholdige farmasoeytiske preparater i flytende form
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
FI892016A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, mahdollisesti -substituoitujen 4-(-kinolin-2-yyli-metoksi)-fenyylietikkahappojen ja -esterien valmistamiseksi
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
FI100769B (fi) Menetelmä triglyseridejä sisältävän farmaseuttisen podofyllotoksiiniva lmisteen valmistamiseksi
DE3664562D1 (en) Process for the preparation of labdane derivatives, and their pharmaceutical use
ZA773259B (en) Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects
HU9201706D0 (en) Process for the production of oxazole derivatives and medical preparation containing them as active agents
ES2066134T3 (es) Usos farmaceuticos de acidos grasos.
HUT40066A (en) Process for production of poliphrens
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
DK89289D0 (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
UA13475A (uk) СПОСІБ ОДЕРЖАННЯ 6-БЕНЗИЛОКСИЗАМІЩЕНИХ ІЗОПРОПІЛОВИХ ЕФІРІВ beta-КАРБОЛІН-3-КАРБОНОВОЇ КИСЛОТИ
FI871479L (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
SE8705035L (sv) Anvaendning av alkylglycerol
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents
NO169323C (no) Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass
HU901875D0 (en) Process for production of galenical preparations providing optimal biological accessibility of 2-hydroxi-5-methyl-laurophenon-oxim as active substance
IL96161A0 (en) Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency
IT7827747A0 (it) Processo per la preparazione di esteri non simmetrici di acidi 1,4-diidropiridin-dicarbossilici eloro impiego come farmaci.
ATE129636T1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
AU3834189A (en) Use of essential fatty acids for the preparation of a drug for the treatment of eczema
DE3578065D1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.